246 related articles for article (PubMed ID: 20224550)
21. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.
Xu Y; Yuan L; Mak J; Pardanaud L; Caunt M; Kasman I; Larrivée B; Del Toro R; Suchting S; Medvinsky A; Silva J; Yang J; Thomas JL; Koch AW; Alitalo K; Eichmann A; Bagri A
J Cell Biol; 2010 Jan; 188(1):115-30. PubMed ID: 20065093
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
23. Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
Chaudary N; Milosevic M; Hill RP
Gynecol Oncol; 2011 Nov; 123(2):393-400. PubMed ID: 21839498
[TBL] [Abstract][Full Text] [Related]
24. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis.
Zhang L; Zhou F; Han W; Shen B; Luo J; Shibuya M; He Y
Cell Res; 2010 Dec; 20(12):1319-31. PubMed ID: 20697430
[TBL] [Abstract][Full Text] [Related]
25. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2.
Gaengel K; Niaudet C; Hagikura K; Laviña B; Muhl L; Hofmann JJ; Ebarasi L; Nyström S; Rymo S; Chen LL; Pang MF; Jin Y; Raschperger E; Roswall P; Schulte D; Benedito R; Larsson J; Hellström M; Fuxe J; Uhlén P; Adams R; Jakobsson L; Majumdar A; Vestweber D; Uv A; Betsholtz C
Dev Cell; 2012 Sep; 23(3):587-99. PubMed ID: 22975327
[TBL] [Abstract][Full Text] [Related]
26. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.
Kawamura H; Li X; Harper SJ; Bates DO; Claesson-Welsh L
Cancer Res; 2008 Jun; 68(12):4683-92. PubMed ID: 18559514
[TBL] [Abstract][Full Text] [Related]
28. VEGFR3 does not sustain retinal angiogenesis without VEGFR2.
Zarkada G; Heinolainen K; Makinen T; Kubota Y; Alitalo K
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):761-6. PubMed ID: 25561555
[TBL] [Abstract][Full Text] [Related]
29. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
30. Expression of VEGFR3 in glioma endothelium correlates with tumor grade.
Grau SJ; Trillsch F; Herms J; Thon N; Nelson PJ; Tonn JC; Goldbrunner R
J Neurooncol; 2007 Apr; 82(2):141-50. PubMed ID: 17115285
[TBL] [Abstract][Full Text] [Related]
31. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
32. SDF-1/CXCR4 contributes to the activation of tip cells and microglia in retinal angiogenesis.
Unoki N; Murakami T; Nishijima K; Ogino K; van Rooijen N; Yoshimura N
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3362-71. PubMed ID: 20181837
[TBL] [Abstract][Full Text] [Related]
33. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
Wang Y; Nakayama M; Pitulescu ME; Schmidt TS; Bochenek ML; Sakakibara A; Adams S; Davy A; Deutsch U; Lüthi U; Barberis A; Benjamin LE; Mäkinen T; Nobes CD; Adams RH
Nature; 2010 May; 465(7297):483-6. PubMed ID: 20445537
[TBL] [Abstract][Full Text] [Related]
34. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas.
Jenny B; Harrison JA; Baetens D; Tille JC; Burkhardt K; Mottaz H; Kiss JZ; Dietrich PY; De Tribolet N; Pizzolato GP; Pepper MS
J Pathol; 2006 May; 209(1):34-43. PubMed ID: 16523449
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
37. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
38. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
39. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns.
Jeltsch M; Karpanen T; Strandin T; Aho K; Lankinen H; Alitalo K
J Biol Chem; 2006 Apr; 281(17):12187-95. PubMed ID: 16505489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
